The development of a quantitative enzyme-linked immunosorbent assay to detect human platelet factor 4

Transfusion

Volumn 45, Issue 5, 2005, Pages 717-724

  Schraw, Todd ^a   Whiteheart, Sidney ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; THROMBOCYTE FACTOR 4;

ACCURACY; ARTICLE; CONCENTRATION (PARAMETERS); COST EFFECTIVENESS ANALYSIS; DILUTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; QUANTITATIVE ASSAY; RELIABILITY; THROMBOCYTE ACTIVATION; THROMBOCYTE RELEASE REACTION;

ANTIBODIES; BACTERIAL PROTEINS; BIOLOGICAL MARKERS; BLOOD PLATELETS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HORSERADISH PEROXIDASE; HUMANS; PLATELET ACTIVATION; PLATELET FACTOR 4;

EID: 18544383153     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2005.04243.x     Document Type: Article

References (17)

1. Holt JC, Niewiarowski S. Biochemistry of alpha granule proteins. Semin Hematol 1985;22:151-63.
2. Dawes J, Smith RC, Pepper DS. The release, distribution, and clearance of human beta-thromboglobulin and platelet factor 4. Thromb Res 1978;12:851-61.
3. McLaren KM, Pepper DS. Immunological localisation of beta-thromboglobulin and platelet factor 4 in human megakaryocytes and platelets. J Clin Pathol 1982;35:1227-31.
4. Levine SP, Knieriem LK, Rager MA. Platelet factor 4 and the platelet secreted proteoglycan: immunologic characterization by crossed immunoelectrophoresis. Blood 1990;75:902-10.
5. Kaser-Glanzmann R, Jakabova M, Luscher EF. Isolation and some properties of the heparin-neutralizing factor (PF4) released from human blood platelets. Experientia 1972;28:1221-3.
6. Zhang X, Chen L, Bancroft DP, et al. Crystal structure of recombinant human platelet factor 4. Biochemistry 1994;33:8361-6.
7. Eslin DE, Zhang C, Samuels KJ, et al. Transgenic mice studies demonstrate a role for platelet factor 4 in thrombosis: dissociation between anticoagulant and antithrombotic effect of heparin. Blood 2004;104:3173-80.
8. Kluter H, Bubel S, Kirchner H, Wilhelm D. Febrile and allergic transfusion reactions after the transfusion of white cell-poor platelet preparations. Transfusion 1999;39:1179-84.
9. Heddle NM, Klama LN, Griffith L, et al. A prospective study to identify the risk factors associated with acute reactions to platelet and red cell transfusions. Transfusion 1993;33:794-7.
10. Holmsen H. Nucleotide metabolism of platelets. Annu Rev Physiol 1985;47:677-90.
11. Bubel S, Wilhelm D, Entelmann M, et al. Chemokines in stored platelet concentrates. Transfusion 1996;36:445-9.
12. Chen D, Lemons PP, Schraw T, Whiteheart SW. Molecular mechanisms of platelet exocytosis: role of SNAP-23 and syntaxin 2 and 4 in lysosome release. Blood 2000;96:1782-8.
13. Chen D, Bernstein AM, Lemons PP, Whiteheart SW. Molecular mechanisms of platelet exocytosis. role of SNAP-23 and syntaxin 2 in dense core granule release. Blood 2000;95:921-9.
14. Davies C. Introduction to immunoassay principles. In: Wild D, editor. The immunoassay handbook. New York: Nature Publishing Group; 2001. p. 17-8.
15. Rutledge TW, Whiteheart SW. Studies of secretion using permeabilized platelets. In: Gibbins JM, Mahaut-Smith MP, editors. Platelets and megakaryocytes. Vol. 1. Functional assays. Totowa (NJ): Humana Press; 2004. p. 109-20.
16. Gurney D, Lip GY, Blann AD. A reliable plasma marker of platelet activation: does it exist? Am J Hematol 2002;70:139-44.
17. Boehlen F, Clemetson KJ. Platelet chemokines and their receptors: what is their relevance to platelet storage and transfusion practice? Transfus Med 2001;11:403-17.